Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Ayada

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|November 10, 2021
Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control StudyJasmijn Z Jagt, Eduard A Struys, Ibrahim Ayada, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 15, 2020
Fecal Amino Acid Profiles Exceed Accuracy of Serum Amino Acids in Diagnosing Pediatric Inflammatory Bowel DiseaseSofie Bosch, Sofia El Manouni El Hassani, Marina Brizzio Brentar, et al.
The Journal of Clinical Investigation|July 14, 2015
Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's diseaseNeil E McCarthy, Charlotte R Hedin, Theodore J Sanders, et al.
Sensors (Basel, Switzerland)|October 19, 2019
Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBDSofia El Manouni El Hassani, Sofie Bosch, Jesse P M Lemmen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2026
Urinary Volatile Organic Compound Metabolites Are Associated With MASLD/MASH in Humans and Induce Steatosis in Liver OrganoidsLaurens A van Kleef, Xincheng Li, Pengfei Li, et al.
Ebiomedicine|December 11, 2022
Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional studyIbrahim Ayada, Laurens A van Kleef, Huai Zhang, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Underuse of statins in MASLD despite population-based associations with lower liver stiffnessJesse Pustjens, Laurens A van Kleef, Jelena Pavlović, et al.
Gastro Hep Advances|January 29, 2025
Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based StudyYasir J Abozaid, Ibrahim Ayada, Laurens A van Kleef, et al.
Hepatology Communications|April 14, 2025
The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysisJiajing Li, Jiahua Zhou, Pengfei Li, et al.
Nature Communications|May 14, 2025
Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic developmentGuige Xu, Jiangrong Zhou, Kuan Liu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|November 10, 2021
Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control StudyJasmijn Z Jagt, Eduard A Struys, Ibrahim Ayada, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 15, 2020
Fecal Amino Acid Profiles Exceed Accuracy of Serum Amino Acids in Diagnosing Pediatric Inflammatory Bowel DiseaseSofie Bosch, Sofia El Manouni El Hassani, Marina Brizzio Brentar, et al.
The Journal of Clinical Investigation|July 14, 2015
Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's diseaseNeil E McCarthy, Charlotte R Hedin, Theodore J Sanders, et al.
Sensors (Basel, Switzerland)|October 19, 2019
Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBDSofia El Manouni El Hassani, Sofie Bosch, Jesse P M Lemmen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2026
Urinary Volatile Organic Compound Metabolites Are Associated With MASLD/MASH in Humans and Induce Steatosis in Liver OrganoidsLaurens A van Kleef, Xincheng Li, Pengfei Li, et al.
Ebiomedicine|December 11, 2022
Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional studyIbrahim Ayada, Laurens A van Kleef, Huai Zhang, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Underuse of statins in MASLD despite population-based associations with lower liver stiffnessJesse Pustjens, Laurens A van Kleef, Jelena Pavlović, et al.
Gastro Hep Advances|January 29, 2025
Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based StudyYasir J Abozaid, Ibrahim Ayada, Laurens A van Kleef, et al.
Hepatology Communications|April 14, 2025
The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysisJiajing Li, Jiahua Zhou, Pengfei Li, et al.
Nature Communications|May 14, 2025
Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic developmentGuige Xu, Jiangrong Zhou, Kuan Liu, et al.
Pageof 4